Nicholson Garry A — SEC Form 4 filings
SEC reporting owner CIK 1640861. 9 Form 4 filings on record with FilingPulse; latest filed 2026-05-22.
Transaction summary — filings shown
Covers all 9 filings on record, filed 2024-05-28 to 2026-05-22. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 25.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Day One Biopharmaceuticals, Inc. (DAWN) | Director | 4 | — | — | 14 |
| G1 Therapeutics, Inc. (GTHX) | Director | 2 | — | — | 7 |
| TScan Therapeutics, Inc. (TCRX) | Director | 3 | — | — | 4 |
Form 4 filings — Nicholson Garry A
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-05-22 | 4 | TScan Therapeutics, Inc. (TCRX) | Grant/award (A): 67,000 (derivative) @ $0 | EDGAR |
| 2026-04-23 | 4 | Day One Biopharmaceuticals, Inc. (DAWN) | Disposition to issuer (D): 33,900 (derivative) · Disposition to issuer (D): 37,500 (derivative) · Disposition to issuer (D): 32,335 (derivative) · Disposition to issuer (D): 22,500 (derivative) · Disposition to issuer (D): 15,000 (derivative) | EDGAR |
| 2025-11-07 | 4 | Day One Biopharmaceuticals, Inc. (DAWN) | Disposition to issuer (D): 33,900 (derivative) @ $0 · Grant/award (A): 33,900 (derivative) @ $0 · Disposition to issuer (D): 37,500 (derivative) @ $0 · Grant/award (A): 37,500 (derivative) @ $0 · Disposition to issuer (D): 32,335 (derivative) @ $0 · Grant/award (A): 32,335 (derivative) @ $0 | EDGAR |
| 2025-07-02 | 4 | TScan Therapeutics, Inc. (TCRX) | Grant/award (A): 67,000 (derivative) @ $0 | EDGAR |
| 2025-06-04 | 4 | Day One Biopharmaceuticals, Inc. (DAWN) | Grant/award (A): 22,500 (derivative) @ $0 · Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2024-09-18 | 4 | G1 Therapeutics, Inc. (GTHX) | Disposition to issuer (D): 20,000 · Code (U): 14,389 · Disposition to issuer (D): 30,000 (derivative) · Disposition to issuer (D): 30,000 (derivative) · Disposition to issuer (D): 30,000 (derivative) | EDGAR |
| 2024-06-14 | 4 | G1 Therapeutics, Inc. (GTHX) | Grant/award (A): 10,000 @ $0 · Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2024-06-14 | 4 | TScan Therapeutics, Inc. (TCRX) | Grant/award (A): 47,500 (derivative) @ $0 · Grant/award (A): 23,750 (derivative) @ $0 | EDGAR |
| 2024-05-28 | 4 | Day One Biopharmaceuticals, Inc. (DAWN) | Grant/award (A): 32,335 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1640861 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →